Publications by authors named "Chad Pecot"

Claim this Profile
F
Feasibility, Acceptability, and Utility of Remote Patient-Reported Outcomes Monitoring in Patients With Lung Cancer: A Moovcare© Study.
Angela M Stover, Allison M Deal, Chaely J Medley, Ashley A Weiner, Lara Novak, Chad V Pecot

Clin Lung Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-targeting RNAi approaches for cancer treatment.
Yogitha S Chareddy, Chad V Pecot

Expert Opin Ther Targets· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diverse roles of quaking in endothelial cell biology.
Lincy Edatt, Danyan Li, Andrew C Dudley, Chad V Pecot

Angiogenesis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A first-in-class EGFR-directed KRAS G12V selective inhibitor.
Lyla J Stanland, Hayden P Huggins, Snehasudha S Sahoo, Alessandro Porrello, Yogitha Chareddy, Chad V Pecot

Cancer Cell· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inverted chimeric RNAi molecules synergistically cotarget MYC and KRAS in KRAS-driven cancers.
Yogitha S Chareddy, Hayden P Huggins, Snehasudha S Sahoo, Lyla J Stanland, Christina Gutierrez-Ford, Chad V Pecot

J Clin Invest· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation Methods of Tumor Endothelial Cells Impact AngiomiR Profiles.
Lincy Edatt, Gargi Dixit, Salma H Azam, Yihsuan S Tsai, Andrew C Dudley, Chad V Pecot

bioRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alcohol use reduces the efficacy of anti-PD1 immunotherapy by disrupting anti-tumor immunity.
Kristen N Gilley, Jason Garness, Ali Khan, Brandon Carpenter, Mitra Shabrang, Chad Pecot

bioRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor suppressors in Sox2-mediated lung cancers promote distinct cell-intrinsic and immunologic remodeling.
Nisitha Sengottuvel, Kristina M Whately, Jennifer L Modliszewski, Rani S Sellers, William D Green, Chad V Pecot

JCI Insight· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Snord67 promotes breast cancer metastasis by guiding U6 modification and modulating the splicing landscape.
Yvonne L Chao, Katherine I Zhou, Kwame K Forbes, Alessandro Porrello, Gabrielle M Gentile, Chad V Pecot

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, Yu Qian, Xin Sun, Chad V Pecot

Nature· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, Yu Qian, Xin Sun, Chad V Pecot

Nature· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generating snoRNA-guided Programmable 2'- -methylation.
Justin Zhao, Eric Cockman, Xinhe Yin, Yvonne Chao, Chad Pecot

bioRxiv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spon1+ inflammatory monocytes promote collagen remodeling and lung cancer metastasis through lipoprotein receptor 8 signaling.
Kristina M Whately, Nisitha Sengottuvel, Lincy Edatt, Sonal Srivastava, Allison T Woods, Chad V Pecot

JCI Insight· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2'--methylation (Nm) in RNA: progress, challenges, and future directions.
Katherine I Zhou, Chad V Pecot, Christopher L Holley

RNA· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Periostin+ Stromal Cells Guide Lymphovascular Invasion by Cancer Cells.
Jamie L Null, Dae Joong Kim, James V McCann, Patcharin Pramoonjago, Jay W Fox, Chad V Pecot

Cancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrated model for predicting KRAS dependency.
Yihsuan S Tsai, Yogitha S Chareddy, Brandon A Price, Joel S Parker, Chad V Pecot

PLoS Comput Biol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzymatic Macrolactamization of mRNA Display Libraries for Inhibitor Selection.
Matthew M Bowler, Marta Glavatskikh, Chad V Pecot, Dmitri Kireev, Albert A Bowers

ACS Chem Biol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer.
Ryan M Murphy, Jason Tasoulas, Alessandro Porrello, Miranda B Carper, Yi-Hsuan Tsai, Chad V Pecot

Cancer Res Commun· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration.
Hongxia Li, Emily B Harrison, Huizhong Li, Koichi Hirabayashi, Jing Chen, Chad V Pecot

Nat Commun· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid idiosyncratic mechanisms of clinical resistance to KRAS G12C inhibition.
Yihsuan S Tsai, Mark G Woodcock, Salma H Azam, Leigh B Thorne, Krishna L Kanchi, Chad V Pecot

J Clin Invest· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer.
Loïc Reppel, Ourania Tsahouridis, Jason Akulian, Ian J Davis, Hong Lee, Chad V Pecot

J Immunother Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silencing of Oncogenic KRAS by Mutant-Selective Small Interfering RNA.
Bjoern Papke, Salma H Azam, Anne Y Feng, Christina Gutierrez-Ford, Hayden Huggins, Chad V Pecot

ACS Pharmacol Transl Sci· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consolidation With Pembrolizumab and Nab-Paclitaxel After Induction Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer.
Shetal A Patel, David E Gerber, Allison Deal, Kathe Douglas, Chad V Pecot

Front Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation of an Orthotopic, Syngeneic Model of Lung Adenocarcinoma and the Testing of the Antitumor Efficacy of Poly(2-oxazoline) Formulation of Chemo-and Immunotherapeutic Agents.
Natasha Vinod, Duhyeong Hwang, Salma H Azam, Amanda E D Van Swearingen, Elizabeth Wayne, Chad V Pecot

Bio Protoc· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation and Characterization of Poly(2-oxazoline) Micelles for the Solubilization and Delivery of Water Insoluble Drugs.
Natasha Vinod, Duhyeong Hwang, Salma H Azam, Amanda E D Van Swearingen, Elizabeth Wayne, Chad V Pecot

Bio Protoc· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis